Hepatitis C Medicine

Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. ... It exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV.

Ledifos Tablet is a combination medicine used for the treatment of chronic hepatitis C infection. This medicine should be used with extreme caution in patients with a known history of hepatitis B infection due to the increased risk of serious adverse reactions.

Ledipasvir is an antiviral medicine used in combination with other medicines for the treatment of chronic hepatitis C infection, genotype 1. This medicine should be used with extreme caution in patients with a known history of hepatitis B infection due to the increased risk of serious adverse reactions.

MyHep LVIR Tablet is a combination medicine used for the treatment of chronic hepatitis C infection. This medicine should be used with extreme caution in patients with a known history of hepatitis B infection due to the increased risk of serious adverse reactions.

Sofosbuvir-velpatasvir is a pangenotypic NS5A-NS5B inhibitor single-pill combination regimen that has potent activity against hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, and 6. It provides a much-needed option for patients with HCV genotype 3 infection, including those with compensated cirrhosis.

Velasof 400mg/100mg Tablet is used in combination with other medications such as ribavirin, daclatasvir and peginterferon to treat chronic hepatitis C. It functions by reducing the hepatitis C virus in the body. This helps to keep liver disorders such as cirrhosis and liver cancer at bay.